G. Ghanem

1.4k total citations
44 papers, 913 citations indexed

About

G. Ghanem is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, G. Ghanem has authored 44 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Cell Biology and 8 papers in Oncology. Recurrent topics in G. Ghanem's work include melanin and skin pigmentation (17 papers), Cell Adhesion Molecules Research (7 papers) and Skin Protection and Aging (6 papers). G. Ghanem is often cited by papers focused on melanin and skin pigmentation (17 papers), Cell Adhesion Molecules Research (7 papers) and Skin Protection and Aging (6 papers). G. Ghanem collaborates with scholars based in Belgium, United Kingdom and United States. G. Ghanem's co-authors include R. Morandini, J.M. Boeynaems, J Vachtenheim, Susan J. Hedley, Hana Novotná, François Salès, S. Mac Neil, Sheila MacNeil, Paula C. Eves and Mark J. Wagner and has published in prestigious journals such as Journal of Clinical Oncology, The FASEB Journal and FEBS Letters.

In The Last Decade

G. Ghanem

44 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Ghanem Belgium 20 407 337 208 205 164 44 913
R. Morandini Belgium 14 254 0.6× 305 0.9× 118 0.6× 145 0.7× 136 0.8× 24 694
Cecilia Herráiz Spain 16 557 1.4× 493 1.5× 209 1.0× 375 1.8× 198 1.2× 26 1.2k
Stéphanie Zdanov Belgium 11 512 1.3× 157 0.5× 185 0.9× 174 0.8× 24 0.1× 12 990
Mika Ikeda Japan 17 868 2.1× 316 0.9× 103 0.5× 68 0.3× 16 0.1× 36 1.3k
Amy Loercher United States 11 367 0.9× 128 0.4× 288 1.4× 232 1.1× 20 0.1× 16 772
Anett Illing Germany 14 263 0.6× 44 0.1× 200 1.0× 127 0.6× 25 0.2× 21 705
Shan Xu China 18 473 1.2× 40 0.1× 317 1.5× 99 0.5× 24 0.1× 33 1.0k
Melanie H. Smith United States 9 519 1.3× 344 1.0× 157 0.8× 143 0.7× 33 0.2× 16 1.0k
Christine Huppertz Switzerland 16 481 1.2× 122 0.4× 154 0.7× 124 0.6× 30 0.2× 20 910
Katherine Drews‐Elger United States 13 514 1.3× 147 0.4× 159 0.8× 359 1.8× 9 0.1× 20 1.0k

Countries citing papers authored by G. Ghanem

Since Specialization
Citations

This map shows the geographic impact of G. Ghanem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Ghanem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Ghanem more than expected).

Fields of papers citing papers by G. Ghanem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Ghanem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Ghanem. The network helps show where G. Ghanem may publish in the future.

Co-authorship network of co-authors of G. Ghanem

This figure shows the co-authorship network connecting the top 25 collaborators of G. Ghanem. A scholar is included among the top collaborators of G. Ghanem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Ghanem. G. Ghanem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghanem, G., James A. Weston, Sarah Persing, et al.. (2024). MicroRNA ‐409‐3p/ BTG2 signaling axis improves impaired angiogenesis and wound healing in obese mice. The FASEB Journal. 38(3). e23459–e23459. 2 indexed citations
2.
Ghanem, G., James A. Weston, Ivana Hollan, et al.. (2023). Deficiency of miR-409-3p improves myocardial neovascularization and function through modulation of DNAJB9/p38 MAPK signaling. Molecular Therapy — Nucleic Acids. 32. 995–1009. 8 indexed citations
3.
Gilot, David, Anne Theunis, Léon C.L.T. van Kempen, et al.. (2015). SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma. British Journal of Cancer. 113(1). 91–98. 27 indexed citations
4.
Journé, Fabrice, Murielle Wiedig, François Salès, et al.. (2013). Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients. British Journal of Cancer. 108(8). 1641–1647. 15 indexed citations
5.
Bron, Dominique, Daniëlle J. Vugts, Marianne Paesmans, et al.. (2012). Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study. Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam). 2 indexed citations
6.
Bouwhuis, Marna G., Stefan Suciu, François Salès, et al.. (2010). Prognostic value of serial blood S100B determinations in stage IIB–III melanoma patients: A corollary study to EORTC trial 18952. European Journal of Cancer. 47(3). 361–368. 34 indexed citations
7.
8.
Duez, Pierre, et al.. (2004). Cysteine but not Glutathione Modulates the Radiosensitivity of Human Melanoma Cells by Affecting Both Survival and DNA Damage. Pigment Cell Research. 17(3). 275–280. 27 indexed citations
9.
Eves, Paula C., John W. Haycock, Chris Layton, et al.. (2003). Anti-inflammatory and anti-invasive effects of α-melanocyte-stimulating hormone in human melanoma cells. British Journal of Cancer. 89(10). 2004–2015. 57 indexed citations
10.
Stoitchkov, Konstantin, S. Letellier, Bernard Bousquet, et al.. (2002). Melanoma progression and serum l-dopa/l-tyrosine ratio: a comparison with S100B. Melanoma Research. 12(3). 255–262. 14 indexed citations
11.
Saurat, J.‐H., et al.. (2002). Urinary excretion of epidermal-type fatty acid-binding protein and S100A7 protein in patients with cutaneous melanoma. Melanoma Research. 12(6). 627–631. 27 indexed citations
12.
Hedley, Susan J., Andrew J. Murray, Karen Sisley, et al.. (2000). α-Melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro. Melanoma Research. 10(4). 323–330. 13 indexed citations
13.
Haycock, John W., Manfred Wagner, R. Morandini, et al.. (1999). α‐MSH Immunomodulation Acts via Rel/NF‐κB in Cutaneous and Ocular Melanocytes and in Melanoma Cells. Annals of the New York Academy of Sciences. 885(1). 396–399. 21 indexed citations
14.
Morandini, R., J.M. Boeynaems, Susan J. Hedley, Sheila MacNeil, & G. Ghanem. (1998). Modulation of ICAM-1 expression by α-MSH in human melanoma cells and melanocytes. Journal of Cellular Physiology. 175(3). 276–282. 46 indexed citations
15.
Morandini, R., et al.. (1994). Receptor‐mediated cyotoxicity of a‐MSH fragments containing melphalan in a human melanoma cell line. International Journal of Cancer. 56(1). 129–133. 20 indexed citations
16.
Süli‐Vargha, Helga, et al.. (1993). Receptor Binding and Cytotoxicity Studies with Melanotropin Fragments Containing Melphalan. Annals of the New York Academy of Sciences. 680(1). 616–618. 2 indexed citations
17.
Liénard, D., et al.. (1993). Local Administration of α‐MSH Exerts a Trophic Effect on the 200‐kDa Neurofilament in Sciatic Rat Nerve. Annals of the New York Academy of Sciences. 680(1). 655–659. 1 indexed citations
18.
Ghanem, G., R. Morandini, Marco d’Ischia, et al.. (1992). Synthesis and cytotoxic properties of new N-substituted 4-aminophenol derivatives with a potential as antimelanoma agents. Melanoma Research. 2(1). 25–32. 11 indexed citations
19.
Ghanem, G., et al.. (1992). Partial characterization of IR-α-MSH peptides found in melanoma tumors. Peptides. 13(5). 989–994. 17 indexed citations
20.
Ghanem, G., et al.. (1989). Alpha‐Melanocyte‐Stimulating Hormone Immunoreactivity in Human Melanoma Metastases Extracts. Pigment Cell Research. 2(6). 519–523. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Morandini Breakdown of academic impact, for papers by Cecilia Herráiz Breakdown of academic impact, for papers by Stéphanie Zdanov Breakdown of academic impact, for papers by Mika Ikeda Breakdown of academic impact, for papers by Amy Loercher Breakdown of academic impact, for papers by Anett Illing Breakdown of academic impact, for papers by Shan Xu Breakdown of academic impact, for papers by Melanie H. Smith Breakdown of academic impact, for papers by Christine Huppertz Breakdown of academic impact, for papers by Katherine Drews‐Elger
Rankless by CCL
2026